Literature DB >> 36243759

The preceding hyponatremia is a useful hallmark for the diagnosis of HHV-6 encephalitis after allogeneic hematopoietic stem cell transplantation.

Shota Yoshida1, Takahide Ara2, Kohei Okada1, Yuto Mori1, Shihori Tsukamoto1, Naoki Miyashita3, Kohei Kasahara1, Ko Ebata1, Junko Iwasaki1, Shojiro Takahashi1, Akio Shigematsu4, Koichiro Minauchi1, Naoki Kobayashi1, Masahiro Ogasawara1, Masahiro Imamura1, Takanori Teshima3, Shuichi Ota1.   

Abstract

Entities:  

Year:  2022        PMID： 36243759     DOI： 10.1038/s41409-022-01843-y

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.174


× No keyword cloud information.
  4 in total

1.  The diagnostic odds ratio: a single indicator of test performance.

Authors:  Afina S Glas; Jeroen G Lijmer; Martin H Prins; Gouke J Bonsel; Patrick M M Bossuyt
Journal:  J Clin Epidemiol       Date:  2003-11       Impact factor: 6.437

Review 2.  Human herpesvirus 6 and central nervous system disease in hematopoietic cell transplantation.

Authors:  Danielle M Zerr
Journal:  J Clin Virol       Date:  2006-12       Impact factor: 3.168

3.  Hyponatremia associated with human herpesvirus-6 (HHV-6) encephalitis after allogeneic hematopoietic stem cell transplantation: A presentation different from HHV-6 myelitis.

Authors:  Koichi Murakami; Sumiko Kohashi; Masatoshi Sakurai; Jun Kato; Takaaki Toyama; Yuya Koda; Yusuke Yamane; Risa Hashida; Ryohei Abe; Rie Yamazaki; Taku Kikuchi; Takayuki Shimizu; Shigeaki Suzuki; Naoki Hasegawa; Shinichiro Okamoto; Takehiko Mori
Journal:  Int J Hematol       Date:  2017-05-13       Impact factor: 2.490

4.  Major central nervous system complications after allogeneic stem cell transplantation: A large retrospective study on 888 consecutive adult patients.

Authors:  Daniele Mannina; Laura Berneking; Anna Both; Wiebke Timm; Tatiana Urbanowicz; Christine Wolschke; Francis Ayuketang Ayuk; Nicole Fischer; Jens Fiehler; Ulrich Grzyska; Sabine Rösner; Chi-Un Choe; Nicolaus Kröger; Maximilian Christopeit
Journal:  Eur J Haematol       Date:  2020-09-27       Impact factor: 2.997
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.